Graf Akcie EXAS (Exact Sciences Corp.). Diskuze k akciím EXAS. Aktuální informace EXAS.

Základní informace o společnosti Exact Sciences Corp. (Akcie EXAS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 16.98B
Hodnota podniku (EV) 19.05B
Tržby 1.712B
EBITDA -787.53
Zisk -864.77
Růst v tržbách Q/Q 61.72 %
Růst v tržbách Y/Y 51.33 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.04
EV/Sales 11.13
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 9.80
P/FCF 190.80
Price/Book 5.94
Účetní hodnota na akcii 16.66
Hotovost na akcii 10.86
FCF vůči ceně 0.52 %
Počet zaměstnanců 4,900
Tržba na zaměstnance 349.306k
Profit margin -56.90 %
Operating margin -63.73 %
Gross margin 76.24 %
EBIT margin -61.48 %
EBITDA margin -46.01 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 77.59 %
EPS - Očekávaný růst příští rok -41.78 %
Return on assets -15.21 %
Return on equity -27.97 %
ROIC -18.06 %
ROCE -17.40 %
Dluhy/Equity 0.74
Čistý dluh/EBITDA -3.04
Current ratio 2.47
Quick Ratio 2.34
Volatilita 3.76
Beta 0.81
RSI 52.49
Cílová cena analytiků 150
Známka akcie (dle analytiků) 1.33
Insider ownership 0.76 %
Institutional ownership 91.14 %
Počet akcií 171.949M
Procento shortovaných akcií 5.53 %
Short ratio 5.14 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2001
Země United States

Finanční výsledky akcie EXAS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,491.391$876.293$454.462$265.989$99.376$39.437
Cost Of Goods Sold$354.324$216.717$116.644$78.305$45.195$24.501
Gross Profit$1,137.067$659.576$337.818$187.684$54.181$14.936
Research And Development Expenses$554.052$139.694$67.285$42.099$33.473$33.914
SG&A Expenses$1,071.635$737.629$427.464$262.912$189.724$140.09
Other Operating Income Or Expenses$23.665-----
Operating Expenses$2,259.41$1,110.075$613.933$384.299$268.392$198.505
Operating Income$-768.019$-233.782$-159.471$-118.31$-169.016$-159.068
Total Non-Operating Income/Expense$-89.086$-35.069$-15.586$3.726$1.805$1.265
Pre-Tax Income$-857.105$-268.851$-175.057$-114.584$-167.211$-157.803
Income Taxes$-8.572$-184.858$0.092$-0.187--
Income After Taxes$-848.533$-83.993$-175.149$-114.397$-167.211$-157.803
Other Income------
Income From Continuous Operations$-848.533$-83.993$-175.149$-114.397$-167.211$-157.803
Income From Discontinued Operations------
Net Income$-848.533$-83.993$-175.149$-114.397$-167.211$-157.803
EBITDA$-320.852$-148.848$-113.733$-104.287$-158.005$-150.524
EBIT$-768.019$-233.782$-159.471$-118.31$-169.016$-159.068
Basic Shares Outstanding15113112211610292
Shares Outstanding15113112211610292
Basic EPS$-5.61$-0.64$-1.43$-0.99$-1.63$-1.71
EPS - Earnings Per Share$-5.61$-0.64$-1.43$-0.99$-1.63$-1.71
# 2020 2019 2018 2017 2016 2015
Current Ratio3.8182.34239.01877.151910.868412.1941
Long-term Debt / Capital0.32240.26560.5030.00810.01560.0176
Debt/Equity Ratio0.56660.36211.01220.00860.01640.0184
Gross Margin76.242175.268974.333670.560854.521237.8731
Operating Margin-51.4968-26.6785-35.0901-44.4793-170.0773-403.3471
EBIT Margin-51.4968-26.6785-35.0901-44.4793-170.0773-403.3471
EBITDA Margin-21.5136-16.9861-25.0259-39.2072-158.9971-381.6822
Pre-Tax Profit Margin-57.4702-30.6805-38.5196-43.0785-168.2609-400.1394
Net Profit Margin-56.8954-9.585-38.5399-43.0082-168.2609-400.1394
Asset Turnover0.30280.250.29820.44440.26360.1083
Inventory Turnover Ratio3.84033.51112.97963.00866.61423.6695
Receiveable Turnover6.39576.72210.025910.068111.65567.9945
Days Sales In Receivables57.069254.299336.405936.253131.315345.6562
ROE - Return On Equity-30.0526-3.6709-25.7216-21.9818-49.8698-48.2791
Return On Tangible Equity-115.0724143.1227-27.5973-23.054-50.1014-48.2791
ROA - Return On Assets-17.2288-2.3959-11.4926-19.112-44.3483-43.3489
ROI - Return On Investment-20.3652-2.6958-12.7829-21.8029-49.0911-47.4302
Book Value Per Share17.710715.4995.52744.31893.04163.381
Operating Cash Flow Per Share1.7537-0.28660.05590.6510.1836-0.4393
Free Cash Flow Per Share-0.0853-0.3673-0.75320.3770.2565-0.5079

Porovnání s konkurencí: Akcie EXAS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
EXAS N/A N/A 51.33 % -41.78 % -27.97 % 5.94 -56.90 %
Akcie ATRS 8.85 0.35 24.41 % 0.00 % 58.38 % 4.87 37.57 %
Akcie BIOC 0.00 N/A 867.07 % -109.30 % -8.72 % 2.21 -64.84 %
Akcie IVC N/A N/A -2.88 % 90.00 % -12.10 % 0.47 -3.32 %
Akcie MYGN N/A 1.40 3.71 % -80.00 % -10.91 % 2.64 -31.24 %
Akcie VCYT 0.00 N/A 39.93 % 137.50 % -9.04 % 7.20 -29.71 %
Akcie WMGI N/A 0.54 -9.88 % -26.32 % -12.70 % 4.37 N/A %

Nedávné obchody insiderů: Akcie EXAS

Jméno Obchod Cena Objem
Kevin T Conroy
President and CEO
Prodej
4 Jan 2021
$128.74 $4,095,734
Kevin T Conroy
President and CEO
Prodej
1 Feb 2021
$138.07 $4,189,596
Kevin T Conroy
President and CEO
Option
5 Feb 2021
$5.70 $99,995
Sarah Condella
SVP and Human Resources
Option
16 Feb 2021
$154.28 $313,188
Kevin T Conroy
President and CEO
Option
16 Feb 2021
$154.28 $4,803,045
D Scott Coward
Chief Administrative Officer
Option
16 Feb 2021
$154.28 $612,800
Jeffrey Thomas Elliott
Chief Financial Officer
Option
16 Feb 2021
$154.28 $612,800
Graham Peter Lidgard
Chief Science Officer
Option
16 Feb 2021
$154.28 $612,800
Jacob A Orville
General Manager and New Ventures
Option
16 Feb 2021
$154.28 $313,188
D Scott Coward
Chief Administrative Officer
Prodej
18 Feb 2021
$140.79 $278,764
Jacob A Orville
General Manager and New Ventures
Option
18 Feb 2021
$141.65 $516,881

Diskuze k akciím EXAS